Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:10 pm Purchase | 2021-12-31 | 13G | Merus N.V. MRUS | Boxer Capital LLC | 1,900,000 4.400% | 300,000 (+18.75%) | Filing History |
| 2022-01-05 9:26 pm Sale | 2022-01-03 | 13D | iTeos Therapeutics, Inc. ITOS | Boxer Capital LLC | 3,717,259 10.540% | -627,757 (-14.45%) | Filing History |
| 2021-11-26 5:01 pm Sale | 2021-11-24 | 13D | Odonate Therapeutics, Inc. ODTC | Boxer Capital LLC | 0 10.900% | -0 (-8.68%) | Filing History |
| 2021-11-22 11:08 am Sale | 2021-11-17 | 13D | Odonate Therapeutics, Inc. ODTC | Boxer Capital LLC | 0 12.000% | -0 (-3.35%) | Filing History |
| 2021-09-24 4:30 pm Purchase | 2021-09-17 | 13D | Tyra Biosciences, Inc. TYRA | Boxer Capital LLC | 6,323,359 14.900% | 6,323,359 (New Position) | Filing History |
| 2021-07-09 4:31 pm Purchase | 2021-06-29 | 13G | Elevation Oncology, Inc. ELEV | Boxer Capital LLC | 1,341,530 5.900% | 1,341,530 (New Position) | Filing History |
| 2021-05-17 4:15 pm Purchase | 2021-05-07 | 13G | F-star Therapeutics, Inc. FSTX | Boxer Capital LLC | 1,501,428 8.200% | 1,501,428 (New Position) | Filing History |
| 2021-05-03 4:30 pm Purchase | 2021-04-27 | 13D | Rain Enhancement Technologies Holdco Inc RAIN | Boxer Capital LLC | 1,894,192 9.990% | 1,894,192 (New Position) | Filing History |
| 2021-04-30 4:45 pm Purchase | 2021-04-20 | 13G | Biomea Fusion, Inc. BMEA | Boxer Capital LLC | 2,088,405 7.300% | 2,088,405 (New Position) | Filing History |
| 2021-02-26 4:40 pm Purchase | 2021-02-17 | 13G | Talis Biomedical Corporation TLIS | Boxer Capital LLC | 103,400 6.000% | 103,400 (New Position) | Filing History |
| 2021-02-16 5:29 pm Purchase | 2020-12-31 | 13G | Cabaletta Bio, Inc. CABA | Boxer Capital LLC | 1,603,361 6.700% | 37,000 (+2.36%) | Filing History |
| 2021-02-16 5:17 pm Sale | 2020-12-31 | 13G | Trillium Therapeutics Inc. TRIL | Boxer Capital LLC | 0 0.000% | -4,425,000 (Position Closed) | Filing History |
| 2021-02-16 5:13 pm Purchase | 2020-12-31 | 13G | Solid Biosciences Inc. SLDB | Boxer Capital LLC | 413,351 9.900% | 151,033 (+57.58%) | Filing History |
| 2021-02-16 5:10 pm Purchase | 2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Boxer Capital LLC | 6,133 4.000% | 3,027 (+97.47%) | Filing History |
| 2021-02-16 5:06 pm Purchase | 2020-12-31 | 13G | Atreca, Inc. BCEL | Boxer Capital LLC | 2,202,333 7.300% | 468,750 (+27.04%) | Filing History |
| 2021-02-16 5:01 pm Purchase | 2020-12-31 | 13G | Matinas BioPharma Holdings, Inc. MTNB | Boxer Capital LLC | 229,573 5.800% | 25,806 (+12.66%) | Filing History |
| 2021-02-16 4:57 pm Purchase | 2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | Boxer Capital LLC | 2,477,194 8.300% | 700,000 (+39.39%) | Filing History |
| 2021-02-16 4:53 pm Purchase | 2020-12-31 | 13G | DBV Technologies S.A. DBVT | Boxer Capital LLC | 188,365 6.800% | 28,750 (+18.01%) | Filing History |
| 2021-02-16 4:50 pm Purchase | 2020-12-31 | 13G | Revolution Medicines, Inc. RVMD | Boxer Capital LLC | 3,309,264 4.600% | 49,500 (+1.52%) | Filing History |
| 2021-02-16 4:43 pm Sale | 2020-12-31 | 13G | Arcus Biosciences, Inc. RCUS | Boxer Capital LLC | 2,084,883 3.200% | -937,508 (-31.02%) | Filing History |